Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
X25-04-ZQ2231-1 |
PEG 350 Da |
Alginate |
Cisplatin |
Inquiry
|
X25-04-ZQ2231-2 |
PEG 550 Da |
Alginate |
Cisplatin |
Inquiry
|
X25-04-ZQ2231-3 |
PEG 750 Da |
Alginate |
Cisplatin |
Inquiry
|
X25-04-ZQ2231-4 |
PEG 1 kDa |
Alginate |
Cisplatin |
Inquiry
|
X25-04-ZQ2231-5 |
PEG 2 kDa |
Alginate |
Cisplatin |
Inquiry
|
X25-04-ZQ2231-6 |
PEG 3 kDa |
Alginate |
Cisplatin |
Inquiry
|
X25-04-ZQ2231-7 |
PEG 4 kDa |
Alginate |
Cisplatin |
Inquiry
|
X25-04-ZQ2231-8 |
PEG 5 kDa |
Alginate |
Cisplatin |
Inquiry
|
X25-04-ZQ2231-9 |
PEG 10 kDa |
Alginate |
Cisplatin |
Inquiry
|
X25-04-ZQ2231-10 |
PEG 20 kDa |
Alginate |
Cisplatin |
Inquiry
|
Properties
Description
This widely used platinum-based anticancer drug conjugate features cisplatin linked to alginate via a polyethylene glycol (PEG) spacer. This high-purity reagent offers the potential for localized and sustained release of cisplatin from alginate-based hydrogels.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
Cisplatin-PEG-alginate is soluble in a wide range of organic solvents, such as DCM, DMF, and DMSO, and shows excellent solubility in water.
Identity
Confirmed by NMR.
Stability
The product is stable for 1 year when stored at the recommended temperature in powder.
Quality Level
Research grade
Applications
Cisplatin-PEG-alginate can be used to study the behavior of this chemotherapy drug with an alginate scaffold for potential cell interaction studies.
Storage
Store at -20°C, protect from light.